BRIEF published on 04/02/2025 at 07:35, 4 hours 29 minutes ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
PRESS RELEASE published on 04/02/2025 at 07:30, 4 hours 34 minutes ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
BRIEF published on 03/26/2025 at 07:35, 7 days 4 hours ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 7 days 4 hours ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 19 days 4 hours ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 19 days 4 hours ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 26 days 4 hours ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 26 days 4 hours ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 1 month 9 days ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
PRESS RELEASE published on 02/21/2025 at 07:30, 1 month 9 days ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
Published on 04/02/2025 at 08:02, 4 hours 2 minutes ago Southern Energy Obtains Approval for Amendment to Outstanding Convertible Debentures
Published on 04/02/2025 at 08:00, 4 hours 4 minutes ago Ondine Biomedical Inc. Announces Mid Yorkshire NHS Trust cuts SSI rates by 71%
Published on 04/02/2025 at 04:00, 8 hours 4 minutes ago MedMira Reports Second Quarter Results FY2025
Published on 04/01/2025 at 23:35, 12 hours 29 minutes ago Amaze Deepens Adobe Express Partnership with New Add-On Experience
Published on 04/01/2025 at 23:20, 12 hours 44 minutes ago RE Royalties Enters into a Letter of Intent to provide a Secured Loan to Revolve for US $8,000,000 to Finance Acquisition of a 9.6 MW Operating Wind Project in the United States
Published on 04/02/2025 at 10:53, 1 hour 11 minutes ago EQS-Adhoc: YOC AG: YOC AG PLANS REVENUES OF EUR 39.0 MILLION TO EUR 41.0 MILLION AND INCREASED PROFITABILITY FOR THE FINANCIAL YEAR 2025
Published on 04/02/2025 at 10:15, 1 hour 49 minutes ago Steyr Motors AG underpins its internationalisation strategy with order from India
Published on 04/02/2025 at 09:03, 3 hours ago FUCHS acquires IRMCO® - Manufacturer of metal forming lubricants
Published on 04/02/2025 at 09:00, 3 hours 4 minutes ago Shelly Group SE: Growth with Smart Locks exceeds expectations
Published on 04/01/2025 at 17:45, 18 hours 19 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 04/01/2025 at 12:31, 23 hours 32 minutes ago Statement of transactions in own shares from March 24, 2025 to March 28, 2025
Published on 04/01/2025 at 08:30, 1 day 3 hours ago Cie du Bois Sauvage: Buy back of own shares – week from 24/03/2025 to 28/03/2025
Published on 03/31/2025 at 19:42, 1 day 16 hours ago Availability of Safran’s 2024 Universal Registration Document (URD)
Published on 03/31/2025 at 19:00, 1 day 17 hours ago Eiffage strengthens its expertise in the offshore energy market with the acquisition of HSM Offshore Energy, a reputable Dutch based EPCIC company
